Clinical Trial Update: Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral miltefosine for the treatment of pediatric cutaneous leishmaniasis in Colombia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: Centro Internacional de Entrenamiento e Investigaciones Médicas | Conditions: Cutaneous Leishmaniasis | Phase 3 | Status: UNKNOWN